Gyre Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2017 | $15.2M | $29.1M | $14.5M |
| Jun 2017 | $9.3M | $39.6M | $32.4M |
| Sep 2017 | $9.5M | $34.4M | $11.0M |
| Dec 2017 | $8.7M | $39.5M | $14.5M |
| Mar 2018 | $3.0M | $145.9M | $126.6M |
| Jun 2018 | $2.6M | $139.5M | $46.5M |
| Sep 2018 | $3.5M | $133.4M | $36.0M |
| Dec 2018 | $5.0M | $124.9M | $31.2M |
| Mar 2019 | $6.1M | $111.9M | $25.0M |
| Jun 2019 | $7.8M | $100.9M | $17.3M |
| Sep 2019 | $10.5M | $91.8M | $23.0M |
| Dec 2019 | $30.2M | $98.6M | $15.4M |
| Mar 2020 | $13.0M | $110.6M | $70.4M |
| Jun 2020 | $14.7M | $123.7M | $59.3M |
| Sep 2020 | $17.7M | $111.8M | $24.9M |
| Dec 2020 | $18.8M | $94.8M | $30.4M |
| Mar 2021 | $15.0M | $119.1M | $83.0M |
| Jun 2021 | $16.6M | $101.8M | $73.6M |
| Sep 2021 | $17.8M | $78.5M | $59.2M |
| Dec 2021 | $14.6M | $55.7M | $44.3M |
| Mar 2022 | $13.2M | $40.3M | $34.8M |
| Jun 2022 | $4.3M | $83.4M | $75.4M |
| Sep 2022 | $1.6M | $31.0M | $23.1M |
| Dec 2022 | $12.5M | $84.8M | $25.2M |
| Mar 2023 | $11.4M | $18.8M | $8.1M |
| Jun 2023 | $7.4M | $12.4M | $6.9M |
| Sep 2023 | $6.4M | $10.0M | $2.2M |
| Dec 2023 | $38.1M | $116.5M | $33.5M |
| Mar 2024 | $33.2M | $122.0M | $29.8M |
| Jun 2024 | $27.6M | $120.9M | $16.1M |
| Sep 2024 | $26.8M | $125.2M | $15.9M |
| Dec 2024 | $27.0M | $125.4M | $11.8M |
| Mar 2025 | $25.5M | $129.8M | $15.0M |
| Jun 2025 | $23.2M | $152.6M | $36.5M |
| Sep 2025 | $22.0M | $159.4M | $40.4M |
| Dec 2025 | $31.4M | $219.8M | $49.2M |
| Mar 2026 | $25.0M | $162.0M | $37.5M |
| Jun 2026 | $34.3M | $199.3M | $43.3M |